These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9858967)

  • 41. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Summaries for patients: Implantable cardioverter-defibrillators in women.
    Ann Intern Med; 2012 Feb; 156(3):I30. PubMed ID: 22312155
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of the patient with implantable cardioverter-defibrillator lead failure.
    Kalahasty G; Ellenbogen KA
    Circulation; 2011 Mar; 123(12):1352-4. PubMed ID: 21444893
    [No Abstract]   [Full Text] [Related]  

  • 45. Far-field oversensing of atrial signals: an unusual cause for very short V-V intervals and inappropriate implantable cardioverter defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2008 Aug; 10(8):1009-11. PubMed ID: 18424788
    [No Abstract]   [Full Text] [Related]  

  • 46. To test or not to test during defibrillator implantation? A reassessment of the conventional wisdom.
    Markowitz SM
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):406-8. PubMed ID: 18298509
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
    Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery.
    Nageh MF; Kim JJ; Chung J; Yao JF
    Europace; 2011 Jan; 13(1):70-6. PubMed ID: 21149512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete extrusion of an implantable cardiac defibrillator.
    Puri R; Khurana S; Young GD
    Europace; 2008 Feb; 10(2):173-4. PubMed ID: 17993454
    [No Abstract]   [Full Text] [Related]  

  • 52. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Defibrillation threshold testing in the 21st century: necessary or not?
    Vlay SC
    Pacing Clin Electrophysiol; 2009 May; 32(5):565-6. PubMed ID: 19422574
    [No Abstract]   [Full Text] [Related]  

  • 54. Implantable rhythm devices and electromagnetic interference: myth or reality?
    Dyrda K; Khairy P
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):823-32. PubMed ID: 18570620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regarding the French Society of Cardiologists' guidelines on the indications for implantable automatic ventricular defibrillators].
    Daubert JC
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):93-4. PubMed ID: 16555690
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiac remote monitoring in France.
    Maillard N; Perrotton F; Delage E; Gourraud JB; Lande G; Solnon A; Probst V; Grimandi G; Clouet J
    Arch Cardiovasc Dis; 2014 Apr; 107(4):253-60. PubMed ID: 24709285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 58. ICD sees what you do not see: how does it beat you?
    Stroobandt SY; Brieda M; Allocca G; Stroobandt RX
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):529-33. PubMed ID: 25546352
    [No Abstract]   [Full Text] [Related]  

  • 59. Lead reliability: How can we do better?
    Love CJ
    Heart Rhythm; 2017 Oct; 14(10):1504-1505. PubMed ID: 28666941
    [No Abstract]   [Full Text] [Related]  

  • 60. Oops!
    Parsonnet V
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1280. PubMed ID: 22816970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.